Prophylactic nadolol or topiramate boosts QOL in migraine Clinical study 02 February 2013 Pages: 1 - 1
International Health Partnership launched, described and supported News item 02 February 2013 Pages: 3 - 3
The WHO is urging for increased investment in mental health services, Media release 02 February 2013 Pages: 3 - 3
Tamoxifen-to-exemestane switch pays off in breast cancer Clinical study 02 February 2013 Pages: 4 - 4
Hospitalisation for preterm and low birth weight (LBW) infants is associated with a significant economic burden, Clinical study 02 February 2013 Pages: 5 - 5
NSAIDs and selective COX-2 inhibitors are still being prescribed in patients with several cardiovascular (CV) risk factors, Clinical study 02 February 2013 Pages: 6 - 6
Greener pastures ahead for those with rhinoconjunctivitis Clinical study 02 February 2013 Pages: 7 - 7
Current best practice for neonatal strep B prevention not ideal Clinical study 02 February 2013 Pages: 9 - 9
Lamivudine of benefit for immune tolerant hep B patients Clinical study 02 February 2013 Pages: 9 - 9
Direct- vs self-administered ART for drug-users with HIV Clinical study 02 February 2013 Pages: 10 - 10
Peginterferon-α-2b/ribavirin protocol of value in chronic HCV Clinical study 02 February 2013 Pages: 10 - 10
Accelerated diagnostic protocol cost saving for TIA Non-clinical study 02 February 2013 Pages: 10 - 10
The International Drug Discovery Institute (iDDi), a non-profit institute involving top scientists, is to launch a global assault on tuberculosis (TB), malaria and HIV. Media release 02 February 2013 Pages: 11 - 11